The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)

NCT00607035 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Olmesartan medoxomil ＋Azelnidipine
DRUG: Olmesartan medoxomil + Hydrochlorothiazide

Sponsor

Jichi Medical University